Cosmetics Export Compliance: MoCRA, CPNP & ANVISA in Practice

Finish a product without deciding the export market first, and a banned ingredient or a non-compliant label will surface right before launch — forcing you to redo the formula, the packaging, and the testing. The US (MoCRA), the EU (CPNP), and Brazil (ANVISA) differ in both procedure and who carries legal responsibility, so compliance is not a last-minute admin task — it is quality design that belongs in the planning phase. Here is what each market asks for, and which documents to secure from your Korean OEM/ODM up front.

1. The regulatory structure to check per market

Market	Core procedure	Local responsible party	Practical checkpoints
US	MoCRA facility registration, product listing	Responsible Person / US distribution lead	Facility info, product category, ingredients, adverse-event handling
EU	CPNP pre-market notification, PIF retention	EU Responsible Person	CPSR safety assessment, full INCI, label language, claim substantiation
Brazil	ANVISA notification or registration	Local importer / license holder	Portuguese label, product grade, ingredient limits, stability data

2. US MoCRA: manage both the facility and the product

The US has tightened cosmetic oversight. Manufacturing and processing facilities may be subject to FDA facility registration, and finished products need a product listing. Brands should organize the manufacturer name and address, product name and category, the full ingredient list, and distribution-responsibility information.

Labeling and post-market duties

Labels need a US contact through which consumers can report adverse events. Serious adverse events must be reported within set deadlines, so you need an internal process that connects customer service, quality, and the manufacturer. Items classified as OTC drugs in the US — such as sunscreens — are not covered by cosmetic MoCRA rules alone.

3. EU CPNP: the safety file is the core

The EU requires CPNP notification before launch, and an EU Responsible Person retains the Product Information File (PIF). The PIF includes the Cosmetic Product Safety Report (CPSR), the method of manufacture, GMP conformity, ingredient data, the label, and claim substantiation.

EU ingredient rules are dense. Preservatives, colorants, UV filters, and fragrance allergens have restriction conditions that update frequently, so confirm them before locking the formula. Words that imply a medicinal effect — like 'whitening' or 'regeneration' — also need market-specific review.

4. Brazil ANVISA: product grade and the local importer

Brazil's path — notification versus registration — depends on product risk. A low-risk product like a basic moisturizer differs from sunscreens, children's products, or special-function items in the level of documentation required. The local importer or license holder is at the center of ANVISA handling, so partner selection is part of your regulatory strategy.

Labels are in Portuguese by default and must carry directions, warnings, importer details, batch number, and expiry per local rules. Brazil is prone to document-mismatch problems at customs, so keep the product name and volume consistent across the invoice, label, and registration file.

5. Documents to line up from your Korean OEM/ODM

For export products, request the 'compliance package' early in development. At minimum you need the INCI full-ingredient list, the concentration range per ingredient, raw-material MSDS, COA, the finished-product specification, microbial testing, stability testing, container compatibility, preservative-efficacy testing, the manufacturing process diagram, batch records, and GMP or ISO 22716 documentation.

From the brand side, balance formula confidentiality against regulatory disclosure. An EU Responsible Person or local agent needs a certain level of concentration data to perform the safety assessment, so define the NDA and the disclosure scope in advance.

6. The practical sequence

Before finalizing the product concept, choose the target markets and review prohibited and restricted ingredients first. Then proceed in order: OEM/ODM formulation, stability testing, label copy, appointing the local responsible party, and finally registration or notification. Export compliance is closer to quality design in the planning phase than to paperwork right before launch.

Sources

• U.S. FDA — Modernization of Cosmetics Regulation Act of 2022 (MoCRA)
• U.S. FDA — Registration & Listing of Cosmetic Product Facilities and Products
• European Commission — Cosmetic Products Notification Portal (CPNP)
• ANVISA (Brazil) — Personal Hygiene Products, Cosmetics and Fragrances